Johnson & Johnson (JNJ) issued an update on its FY12 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $5.05-5.10 for the period.

Shares of Johnson & Johnson (JNJ) opened at 68.60 on Tuesday. Johnson & Johnson (JNJ) has a 52 week low of $61.05 and a 52 week high of $69.75. The company has a market cap of $189.1 billion and a P/E ratio of 21.79.

Johnson & Johnson last announced its earnings results on Tuesday, October 16th. The company reported $1.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.04. Johnson & Johnson’s revenue was up 6.5% compared to the same quarter last year. Analysts expect that Johnson & Johnson (JNJ) will post $5.07 EPS for the current fiscal year.

Several analysts have also recently commented on the stock. Analysts at Jefferies Group reiterated a buy rating on shares of Johnson & Johnson in a research note to investors on Friday. They now have a $78.00 price target on the stock. On a related note, analysts at Goldman Sachs downgraded shares of Johnson & Johnson from a neutral rating to a sell rating in a research note to investors on Tuesday, October 9th. They now have a $72.00 price target on the stock. They noted that the move was a valuation call. Finally, analysts at Wells Fargo & Co. reiterated an outperform rating on shares of Johnson & Johnson in a research note to investors on Friday, October 5th.

Johnson & Johnson is a holding company. The Company, along with its subsidiaries, is engaged in the research and development, manufacture and sale of a range of products in the healthcare field.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.